Stock Information
CytomX Therapeutics Inc (CTMX)
Ticker Symbol: CTMX
Exchange: NASDAQ
Sector: N/A
Market Cap: $0.00 mil
Piotroski score: 2
PE Ratio: 26.548
EPS (TTM): 0.4026
Revenue (TTM): $0.69 M
Dividend Yield: N/A%
ROE: 10.87%
Latest News
-
CytomX Therapeutics: EpCAM Is Back, Now Prove It Holds (Rating Downgrade)
Wed, Dec 24, 2025 7:00 AM
Key Financials
Financial data not available
